View printer-friendly version << Back

LeMaitre Vascular to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference on Wednesday, March 1, 2017

02/23/17

BURLINGTON, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will participate in BTIG’s 2017 Medical Technology, Life Science and Diagnostic Tools Conference on Wednesday, March 1, 2017 in Snowbird, UT.

About LeMaitre Vascular                                    

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

Contact:  LeMaitre Vascular, Inc.
Steven Chehames
Investor Relations
+1-781-425-1659
schehames@lemaitre.com

Primary Logo

LeMaitre Vascular, Inc.